- Feature Stories
- News Flash
- Making Noise
- The Fence
- Beyond the Cut
- Inspire Innovation
Cover Story: He Did It
Fourteen hours after entering the world, Noah Rothberg stops breathing. His skin turns blue, his blood unable to feed his cells and tissues with enough oxygen. In a terrifying instant, the hospital room swarms with medical personnel. The newborn is rushed from the protective cradle of his mother’s arms to the neonatal intensive care unit. The NICU is dimly lit, with the drone of beeping monitors and wheezing respirators punctuated by the occasional infant’s cry or alarm. Specialists stabilize Noah, placing him in an incubator to warm his tiny body. He is placed under oxygen. An IV delivers fluids and drugs. Chest wires track...Read More
In This Issue
January 2012, Vol. 9 No. 1
Welcome in the new year by learning in “He Did It!” how Jonathan Rothberg (E’85, Trustee) created a gene machine that could change healthcare forever. He devised it when his son was fighting for his life. It’s one of several remarkable stories in the January issue that will take you to from a blockbuster musical in “Broadway Bound” to a revolutionary Turkish power plant in “Fired Up.”View the e-Edition »
Having never met until their first day freshman year at Carnegie Mellon, Josh Gad and Rory O’Malley were two aspiring actors who had big dreams. Throughout their college years and after graduation, their dreams became intertwined in a way that seems much closer to a Hollywood script than actual reality.
The two men grew up in different countries,yet with much in common. Both of them, Paul Browning and Kerem Metin, even graduated from Carnegie Mellon. But they never met; they never knew the other existed until plans for a revolutionary power plant made their lives intersect in a dramatic way.
High On Research
Recreational drugs and their impact on society have been grabbing headlines for decades—everything from their effect on users to whether they should be legalized. For Carnegie Mellon professor Jonathan Caulkins, drugs have been more than headlines; analyzing drug policy has been a large part of his career.